mesalazine (Asacol®)
HAW0105
Phase 3 small_molecule completed
Quick answer
mesalazine (Asacol®) for Ulcerative Colitis is a Phase 3 program (small_molecule) at Cardiff Oncology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cardiff Oncology
- Indication
- Ulcerative Colitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed